OCTAPHARMA AG
Patent Owner
Stats
- 32 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 32 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 535 Total Citation Count
- Dec 24, 1991 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0189,494 PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIMar 20, 17Jul 06, 17[A61K]
2016/0340,410 A PROCESS FOR MANUFACTURING FACTOR VIII HAVING AN IMPROVED RATIO OF FVIII:C/FVIII:AGJan 20, 15Nov 24, 16[C07K]
2016/0152,661 PROCESS FOR ISOLATION AND PURIFICATION OF A TARGET PROTEIN FREE OF PRION PROTEIN (PRPSC)Dec 29, 15Jun 02, 16[C07K, B01D]
2015/0190,478 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIDec 11, 14Jul 09, 15[A61K]
2013/0079,498 PROCESS FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IXMar 30, 11Mar 28, 13[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9901597 Method for inactivation/removal of coagulation factors by precipitationFeb 03, 12Feb 27, 18[A61K, C07K]
9796986 Serum-free stable transfection and production of recombinant human proteins in human cell linesDec 05, 16Oct 24, 17[C12N, C07K]
9512457 Serum-free stable transfection and production of recombinant human proteins in human cell linesFeb 01, 16Dec 06, 16[C12P, C12N, C07K]
9388402 Method for improved isolation of recombinantly produced proteinsMar 29, 06Jul 12, 16[C12P, C12N, C07K]
9120873 Recombinantly produced human factor VIII and IXAug 21, 09Sep 01, 15[A61K, C07H, C12P, C12N, C07K]
9115381 Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIIIMay 14, 12Aug 25, 15[C12P, C12N, C07K]
8962813 Purification and use of a factor for supporting wound healingJan 25, 07Feb 24, 15[A61K, A23J, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0250,879 TEST FOR HEMOLYTIC POTENTIAL OF PHARMACEUTICAL PRODUCTS AND FORMULATIONS FOR RISK MINIMIZATIONAbandonedSep 26, 13Sep 10, 15[A61K, G01N, C07K]
2014/0051,839 Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation FactorsAbandonedNov 16, 11Feb 20, 14[C07K]
8518452 Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acidExpiredFeb 15, 08Aug 27, 13[A61K]
2011/0178,019 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIAbandonedSep 03, 09Jul 21, 11[A61K, A61P]
2011/0104,298 Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasmaAbandonedAug 24, 10May 05, 11[A61K]
2010/0330,568 ASSAY AND METHOD FOR THE ASSESSMENT OF RESPONDERS AND NON-RESPONDERS TO NK CELL MODULATION BY IMMUNOGLOBULIN THERAPYAbandonedJan 09, 09Dec 30, 10[C12Q]
2008/0172,902 Lyophilisation targeting defined residual moisture by limited desorption energy levelsAbandonedJun 19, 07Jul 24, 08[F26B]
2007/0071,829 Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasmaAbandonedDec 20, 04Mar 29, 07[A61K, C12N]
2006/0234,907 Albumin solution and process for the production thereofAbandonedFeb 13, 04Oct 19, 06[C07K]
2006/0194,300 Process for preparing an alpha-1-antitrypsin solutionAbandonedAug 12, 04Aug 31, 06[C12N]
6893856 Process for preparing virus-inactivated factors 1X and X by membrane chromatographyExpiredMay 02, 02May 17, 05[C12N, C02F]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
